Skip to main content
. 2020 Feb 22;111(4):1241–1253. doi: 10.1111/cas.14337

Figure 7.

Figure 7

Model of proposed molecular mechanism underlying angiopoietin‐like protein 2 (ANGPTL2)‐mediated metabolic reprogramming. In lung cancer cells, tumor cell‐derived ANGPTL2 activates the transforming growth factor‐β (TGF‐β)‐zinc finger E‐box binding homeobox 1 (ZEB1) pathway through integrin α5β1‐ERK and induces not only the epithelial‐mesenchymal transition (EMT) but also glucose transporter 3 (GLUT3) expression, enhancing glycolytic metabolism